In addition, the CTS + IL-1β treatment significantly downregulated COL1A1 by AF cells (*p < 0.05) and upregulated elastin (**p < 0.01), a key AF protein involved in tissue elasticity, compared to CTS-treated cells (Figures 3C,D). This evidence concerns the gene IL1B and atrial fibrillation.